- Sustainability
- DE&I
- Pandemic
- Finance
- Legal
- Technology
- Regulatory
- Global
- Pricing
- Strategy
- R&D/Clinical Trials
- Opinion
- Executive Roundtable
- Sales & Marketing
- Executive Profiles
- Leadership
- Market Access
- Patient Engagement
- Supply Chain
- Industry Trends
European Medicines Verification System Moves Forward with Germany Connection
July 23, 2015.
The European Medicines Verification System (EMVS) has implemented its first hub connection with a member state, marking, EFPIA reports, "a major step along the road to securing the legitimate pharmaceutical supply chain against the risk of falsified medicines".
On July 1, the link was established between the European hub and the German repository system, managed by the German stakeholder organisation securPharm. Pharmaceutical manufacturers will now be able to upload their serialised data onto the system. Sixteen companies have so far committed to take part in the rollout of the system and to establish a connection with the hub.
Andreas Walter, EMVO Director General, commented that the EMVO/Hub "is now capable of comprehensibly: securing cross-border trade; ensuring interoperability between national systems; supporting the establishment of standard interfaces and providing cost savings for connecting manufacturers at a single entry point”.
